Sunita Chadha, M.D.

Medicare Part B Activity

Reported 43,619 Medicare fee-for-service service lines in 2024.

Activity Percentile

98.8%

Rank by Services

8 of 665

Total Services

43,619

Est. Allowed Value

$300,988.21

Dataset Year

2024

Drug Code Share

97.5%

Estimated allowed value reflects Medicare fee-for-service allowed amounts only. It does not include Medicare Advantage, commercial insurance, cash-pay services, or employment compensation.

Peers are grouped by the broader Internal Medicine classification rather than the exact subspecialty label shown elsewhere on the page.

Drug-related HCPCS codes make up 97.5% of reported Medicare services, so the claim mix is dominated by administered-drug billing lines.

Top Clinical Services

• 99213: Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more

  314 services | $25,136.01

• 96365: Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

  282 services | $14,715.67

• G2211: Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's

  240 services | $3,473.27

• 99214: Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more

  110 services | $12,670.32

• 96366: Infusion into a vein for therapy, prevention, or diagnosis, each additional hour

  62 services | $1,107.72

Common Drug-Related Codes

• J3262: Injection, tocilizumab, 1 mg

  39,081 services | $194,092.92

• J1010: Injection, methylprednisolone acetate, 1 mg

  1,688 services | $219.64

• J0897: Injection, denosumab, 1 mg

  1,680 services | $43,030.41